Final keynote speaker confirmed: Onno van de Stolpe, CEO Galapagos

Final keynote speaker confirmed: Onno van de Stolpe, CEO Galapagos

October 25, 2016

The ambition of Galapagos is to become a leading global biotechnology company focused on the development and commercialization of novel medicines. The strategy underlying this ambition will be presented by CEO Onno van der Stolpe on the basis of the development and commercialization strategy of Filgotinib.

Invitation to participate in the Investors Forum

Invitation to participate in the Investors Forum

September 26, 2016

The Investors Forum is an exciting opportunity for those companies looking for equity capital and/or partnerships with companies and institutes across the life sciences value chain, from biotech, med tech and pharma companies to financiers and universities.

Stay up to date with the latest news!

Newsletter subscribe